Vincenzo Di Marzo

Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (MEND) at Laval University

Department of Medicine, Faculty of Medicine, Université Laval, Québec, QC, Canada
Centre Nutrition, santé et société (NUTRISS), Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec, QC, Canada
École de nutrition, Faculté des sciences de l’agriculture et de l’alimentation, Université Laval, Québec, QC, Canada
Institute of Biomolecular Chemistry, Italian Consiglio Nazionale delle Ricerche, Naples, Italy

Dr. Vincenzo Di Marzo is Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND) at Laval University, Quebec, Canada, and associated Research Director at the Institute of Biomolecular Chemistry of the National Research Council (ICB-CNR) in Pozzuoli, Italy. He is also the coordinator of the Endocannabinoid Research Group in the Naples region, and the director of the Joint International Research Unit between the Italian National Research Council and Université Laval, for Chemical and Biomolecular Research on the Microbiome and its impact on Metabolic Health and Nutrition (MicroMeNu,

He holds a ChemD from the University of Naples in 1983, and a PhD in Biochemistry from Imperial College in London in 1988. He is co-author of about 750 articles published in peer-reviewed journals (H index 128 according to Scopus). In 2014-2020 he has been listed for 7 consecutive years among the Highly Cited Researchers (top 1% in the world) in all scientific disciplines. He has been the recipient of numerous research grants and awards, including: a Human Frontier Science Program research grant to study the biosynthesis, metabolism, and structure-activity relationships of anandamide; a Merkator Fellowship for Foreign Scientists by the Deutsche Forschungsgemeinshaft; the Mechoulam Award for “his outstanding contributions to cannabinoid research”; the Luigi Tartufari award for Chemistry from the Italian Academy of Sciences (Accademia dei Lincei); the “Ester Fride Award for Basic Science” from the International Association for Cannabinoid Medicines. In October 2014 he was awarded the International Award “Guido Dorso” for Research, and in May 2016 the Medal of the Italian Accademia delle Scienze, or of the XL, for Physical and Natural Sciences. In In November 2018 he was elected member of the Italian “Accademia dei Lincei”, the oldest academy of the sciences in the world. Ranked 492 in a new citation index covering nearly 7 million researchers worldwide and 100,000 highly cited authors (Ioannidis JPA, Baas J, Klavans R, Boyack KW (2019) A standardized citation metrics author database annotated for scientific field. PLoS Biol 17(8): e3000384. Ranked 528 in the latest Mendeley “Updated science-wide author databases of standardized citation indicators” special classification including 159683 highly cited authors.

Areas of Interest

  • Cannabinoids
  • CNS complications of obesity
  • Endocannabinoids
  • Gut microbiome
  • Obesity
  • Type 2 diabetes